申请人:Abbott Laboratories
公开号:US08293738B2
公开(公告)日:2012-10-23
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts,
wherein A1, A2, A3 and L are defined in the description. The present invention relates also to methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as aurora and KDR.
本发明涉及式(I)化合物或药物可接受的盐,其中A1、A2、A3和L在说明书中有定义。本发明还涉及制备所述化合物的方法以及含有所述化合物的组合物,其对抑制aurora和KDR等激酶具有有用的作用。